A human bone morphogenetic protein antagonist is down-regulated in renal cancer.
Blish KR, Wang W, Willingham MC, Du W, Birse CE, Krishnan SR, Brown JC, Hawkins GA, Garvin AJ, D'Agostino RB Jr, Torti FM, Torti SV.
Blish KR, et al. Among authors: hawkins ga.
Mol Biol Cell. 2008 Feb;19(2):457-64. doi: 10.1091/mbc.e07-05-0433. Epub 2007 Nov 21.
Mol Biol Cell. 2008.
PMID: 18032587
Free PMC article.